TB-101

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameTB-101
Drug Alias NameTB-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGalectin-3 inhibitors
TargetsGalectin-3
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTrueBinding Inc
China Registration ClassN/A

Develop Information

Active CompaniesTrueBinding Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A